Baird Financial Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,435
| Closed | -$23.1K | – | 1784 |
|
|
2023
Q2 | $23.1K | Sell |
10,435
-25,065
| -71% | -$55.4K | ﹤0.01% | 1678 |
|
|
2023
Q1 | $90.2K | Hold |
35,500
| – | – | ﹤0.01% | 1657 |
|
|
2022
Q4 | $66K | Sell |
35,500
-13,570
| -28% | -$25.2K | ﹤0.01% | 1664 |
|
|
2022
Q3 | $126K | Buy |
49,070
+5,570
| +13% | +$14.3K | ﹤0.01% | 1654 |
|
|
2022
Q2 | $84K | Sell |
43,500
-1,675
| -4% | -$3.23K | ﹤0.01% | 1749 |
|
|
2022
Q1 | $134K | Buy |
45,175
+550
| +1% | +$1.63K | ﹤0.01% | 1774 |
|
|
2021
Q4 | $200K | Sell |
44,625
-5,900
| -12% | -$26.4K | ﹤0.01% | 1820 |
|
|
2021
Q3 | $246K | Sell |
50,525
-1,880
| -4% | -$9.15K | ﹤0.01% | 1738 |
|
|
2021
Q2 | $357K | Buy |
52,405
+500
| +1% | +$3.41K | ﹤0.01% | 1521 |
|
|
2021
Q1 | $366K | Hold |
51,905
| – | – | ﹤0.01% | 1454 |
|
|
2020
Q4 | $325K | Sell |
51,905
-1,900
| -4% | -$11.9K | ﹤0.01% | 1354 |
|
|
2020
Q3 | $291K | Sell |
53,805
-1,500
| -3% | -$8.11K | ﹤0.01% | 1307 |
|
|
2020
Q2 | $289K | Buy |
55,305
+5,300
| +11% | +$27.7K | ﹤0.01% | 1311 |
|
|
2020
Q1 | $158K | Buy |
50,005
+3,900
| +8% | +$12.3K | ﹤0.01% | 1352 |
|
|
2019
Q4 | $186K | Buy |
46,105
+380
| +0.8% | +$1.53K | ﹤0.01% | 1466 |
|
|
2019
Q3 | $198K | Buy |
45,725
+1,499
| +3% | +$6.49K | ﹤0.01% | 1446 |
|
|
2019
Q2 | $176K | Buy |
44,226
+4,458
| +11% | +$17.7K | ﹤0.01% | 1479 |
|
|
2019
Q1 | $213K | Sell |
39,768
-108,764
| -73% | -$583K | ﹤0.01% | 1232 |
|
|
2018
Q4 | $762K | Buy |
148,532
+10,436
| +8% | +$53.5K | 0.01% | 876 |
|
|
2018
Q3 | $1.34M | Buy |
138,096
+58,765
| +74% | +$572K | 0.01% | 775 |
|
|
2018
Q2 | $809K | Buy |
+79,331
| New | +$809K | 0.01% | 881 |
|
|
2017
Q1 | – | Sell |
-14,021
| Closed | -$216K | – | 1257 |
|
|
2016
Q4 | $216K | Buy |
+14,021
| New | +$216K | ﹤0.01% | 1125 |
|